Sai Parental's Ltd. on Wednesday announced the price band for its upcoming initial public offering worth Rs 409 crore. The IPO is a combination of fresh issue of 0.73 crore shares aggregating to Rs 285 crore and offer for sale of 0.32 crore shares aggregating to Rs 124 crore. Investors can bid for shares in the range of Rs 372 to Rs 392.
The lot size is 38 equity shares, requiring a minimum investment of Rs 14,896. The total IPO size is Rs 409 crore based on the upper price band and the company will be valued at Rs 1,732 crore.
The subscription will open on March 24 and close on March 27. The anchor bidding round will be held on March 23.
The allotment for the Sai Parental IPO will be finalised on March 30 and the shares will be credited to the demat account on April 1. The stock will list on the BSE and NSE on April 2.
Arihant Capital Markets Ltd. is the book running lead manager.
ALSO READ: Coal India Arm Central Mine Planning & Design Institute IPO Price Band Out — Check Bidding Details
Sai Parenteral's is a diversified pharmaceutical formulations company with expertise in research, development, and manufacturing. The company operates in two segments: Branded Generic Formulations and Contract Development and Manufacturing Organisation (CDMO) products and services for domestic and international markets.
The product portfolio spans multiple therapeutic areas including cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements (VMS), analgesics, and dermatology. Offerings are across dosage forms such as injectables, tablets, capsules, liquid orals, and ointments.
Of the fresh issue raise, the company will utilise for Rs 111 crore for capacity expansion and upgradation of manufacturing facilities.
ALSO READ: RBL Bank Appointed As Collecting Banker To First IPO From GIFT IFSC